Clinical trial Recruiting at 2 sites Interventional Ages 18 and up

Treating elevated blood pressure during hospital stays to see if it changes outcomes

Official title: Evaluating Whether Treating Elevated Blood Pressure in the Inpatient Setting Impacts Patient Outcomes: the ACT-BP Pilot

Run by The Cleveland Clinic · NCT07208669 · Data updated 2026-11-12

We are testing whether changing how hospitals respond to briefly high blood pressure in adults on general medical units reduces unnecessary increases in blood-pressure medicines and improves patient outcomes.

More Blood Pressure Control trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment4 (estimated)
SponsorThe Cleveland Clinic
Academic / other
Locations2 sites (Cleveland, Ohio and 1 other locations)
StatusRecruiting
StartedNovember 11, 2025
Main results expectedDecember 31, 2026
Study endsJuly 31, 2027
Registry record updatedJanuary 8, 2026
Trial IDNCT07208669 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with hypertension admitted to non-ICU general medical units who have asymptomatic elevated blood pressure readings and do not meet exclusion criteria are the intended candidates.

Probably not a fit

Patients with hypertensive emergencies or active cardiovascular events, those on dialysis or with end-stage renal disease, pregnant or postpartum women, very short or prolonged hospital stays, ICU transfers, or those whose systolic BP stays below 160 mmHg are unlikely to benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This unit-level intervention called ACT-BP removes standing orders that prompt automatic physician notification for elevated blood pressures, provides education about potential harms of treating asymptomatic inpatient BP elevations, and suggests alternatives such as more frequent monitoring and nonpharmacologic measures. The intervention is implemented at the hospital-unit level on general medical wards and outcomes include the rate of antihypertensive medication intensification and downstream patient events. The study is designed to generate the key feasibility and outcome data needed to plan a larger cluster-randomized trial that will determine whether inpatient intensification affects readmissions and adverse events. Enrollment excludes patients with hypertensive emergencies, active cardiovascular events, dialysis-dependent renal failure, pregnancy, very short or very long stays, ICU transfers, or systolic BP that remains below 160 mmHg during hospitalization.

Why it matters

Potential benefit: If successful, the approach could reduce unnecessary increases in blood-pressure medications and lower related harms such as readmissions and adverse events.

How similar studies have gone: Observational studies have suggested potential harm from inpatient antihypertensive medication intensification, but randomized evidence is lacking and unit-level interventions like ACT-BP are relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* At the unit level: Medical units that do not typically care for patients requiring step-down care.

Exclusion Criteria:

1. Patients less than 18
2. Patients experiencing hypertensive emergencies or cardiac symptoms
3. Patients with active cardiovascular events, such as

   * Stroke
   * Non-ST-elevation
   * Myocardial infarction
   * End-stage renal disease
   * Patients on dialysis
   * Those with acute decompensated heart failure

3\. Patients on the unit for more than 10 days

4\. Patients transferred in after being in the intensive care unit (ICU)

5\. Pregnant and post-partum women

6\. Patients discharged within 24 hours of admission

7\. Patients whose systolic BP remains below 160 mmHg during hospitalization.

Where it's running

  • Cleveland Clinic Main Campus
    Cleveland, Ohio, United States
    Recruiting
  • Cleveland Clinic Hillcrest
    Mayfield Heights, Ohio, United States
    Recruiting

Study contacts

  • Principal investigator: Elizabeth Pfoh, PhD, MPH — The Cleveland Clinic
  • Study coordinator: Elizabeth Pfoh, PhD, MPH
  • Email: pfohe@ccf.org
  • Phone: 12162963034

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.